中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2014年
21期
83-84
,共2页
杜坤俊%冯振华%邱光进%杨红%黄强
杜坤俊%馮振華%邱光進%楊紅%黃彊
두곤준%풍진화%구광진%양홍%황강
膀胱癌%术后%膀胱内灌注化疗%护理
膀胱癌%術後%膀胱內灌註化療%護理
방광암%술후%방광내관주화료%호리
Bladder cancer%Postoperative intravesical chemotherapy%Nursing
目的:探讨膀胱癌术后膀胱内灌注化疗药物的护理体会情况。方法分析我院2012年9月至2014年3月收治的膀胱肿瘤术后膀胱灌注化疗患者83例临床资料,依据灌注化疗方法不同进行分组,手工膀胱灌注化疗组68例(200例次)和采用广州保瑞医疗公司的BR-TRG-I型体腔热灌注治疗系统进行膀胱热灌注化疗组15例(53例次)。结果复查膀胱镜显示:采用广州保瑞医疗公司的BR-TRG-I型体腔热灌注治疗系统进行膀胱热灌注化疗组患者临床治疗有效率明显高于手工膀胱灌注化疗组,采用广州保瑞医疗公司的BR-TRG-I型体腔热灌注治疗系统进行膀胱热灌注化疗组患者不良反应发生率和复发率均明显低于手工膀胱灌注化疗组,P<0.05,差异均有统计学意义。结论采用广州保瑞医疗公司的BR-TRG-I型体腔热灌注治疗系统进行膀胱热灌注化疗可以有效地防止膀胱癌术后复发,提高膀胱内灌注化疗患者疗效,降低不良反应发生率,值得临床推广应用。
目的:探討膀胱癌術後膀胱內灌註化療藥物的護理體會情況。方法分析我院2012年9月至2014年3月收治的膀胱腫瘤術後膀胱灌註化療患者83例臨床資料,依據灌註化療方法不同進行分組,手工膀胱灌註化療組68例(200例次)和採用廣州保瑞醫療公司的BR-TRG-I型體腔熱灌註治療繫統進行膀胱熱灌註化療組15例(53例次)。結果複查膀胱鏡顯示:採用廣州保瑞醫療公司的BR-TRG-I型體腔熱灌註治療繫統進行膀胱熱灌註化療組患者臨床治療有效率明顯高于手工膀胱灌註化療組,採用廣州保瑞醫療公司的BR-TRG-I型體腔熱灌註治療繫統進行膀胱熱灌註化療組患者不良反應髮生率和複髮率均明顯低于手工膀胱灌註化療組,P<0.05,差異均有統計學意義。結論採用廣州保瑞醫療公司的BR-TRG-I型體腔熱灌註治療繫統進行膀胱熱灌註化療可以有效地防止膀胱癌術後複髮,提高膀胱內灌註化療患者療效,降低不良反應髮生率,值得臨床推廣應用。
목적:탐토방광암술후방광내관주화료약물적호리체회정황。방법분석아원2012년9월지2014년3월수치적방광종류술후방광관주화료환자83례림상자료,의거관주화료방법불동진행분조,수공방광관주화료조68례(200례차)화채용엄주보서의료공사적BR-TRG-I형체강열관주치료계통진행방광열관주화료조15례(53례차)。결과복사방광경현시:채용엄주보서의료공사적BR-TRG-I형체강열관주치료계통진행방광열관주화료조환자림상치료유효솔명현고우수공방광관주화료조,채용엄주보서의료공사적BR-TRG-I형체강열관주치료계통진행방광열관주화료조환자불량반응발생솔화복발솔균명현저우수공방광관주화료조,P<0.05,차이균유통계학의의。결론채용엄주보서의료공사적BR-TRG-I형체강열관주치료계통진행방광열관주화료가이유효지방지방광암술후복발,제고방광내관주화료환자료효,강저불량반응발생솔,치득림상추엄응용。
Objective To approach Nursing experience of Intravesical chemotherapy after operation of Bladder cancer. Method To analzye 83 cases clinical data of intravesical chemotherapy after operation of bladder cancer patients in our hospital from 2012.9 to 2014.3, which was to be divided into two groups, manual bladder perfusion chemotherapy group 68 cases(200 person-time)and Bladder perfusion chemotherapy group of the BR-TRG-I hyperthermic perfusion treatment system of Guangzhou bright medical company 15 cases(53 person-time). Result Cystoscopy revealed:clinical efficiency of bladder perfusion chemotherapy group of the BR-TRG-I hyperthermic perfusion treatment system of Guangzhou bright medical company was higher than manual bladder perfusion chemotherapy group, the incidence of adverse reactions and recurrence rate of the BR-TRG-I hyperthermic perfusion treatment system of Guangzhou bright medical company was lower than manual bladder perfusion chemotherapy group, P<0.05, the difference were statistical significance. Conclusion Postoperative recurrence of bladder cancer of the BR-TRG-I hyperthermic perfusion treatment system of Guangzhou bright medical company were effectively prevent, the intravesical chemotherapy patients was increased, the incidence of adverse reaction was decreased,which was to be used.